BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND ETV5, P41161, 2119, ENSG00000244405, ERM
41 results:

  • 1. Docetaxel-Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15-Year Retrospective Analysis from a Regional Upper Gastrointestinal cancer Network.
    Tankel J; Ahmed N; Mueller C; Najmeh S; Spicer J; Mulder D; Cool-Lartigue J; Rousseau M; Frechette D; Sud S; Kavan P; Moghrabi A; Champagne M; Lemay F; Dalfen R; Sirhan S; Asselah J; Alcindor T; Ferri L
    Ann Surg Oncol; 2024 Apr; 31(4):2461-2469. PubMed ID: 38142255
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. TAOK3 Facilitates Esophageal Squamous Cell Carcinoma Progression and Cisplatin Resistance Through Augmenting Autophagy Mediated by IRGM.
    Sun M; Li Z; Wang X; Zhao M; Chu Y; Zhang Z; Fang K; Zhao Z; Feng A; Leng Z; Shi J; Zhang L; Chen T; Xu M
    Adv Sci (Weinh); 2023 Oct; 10(29):e2300864. PubMed ID: 37705061
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prenylated PALM2 Promotes the Migration of Esophageal Squamous Cell Carcinoma Cells Through Activating Ezrin.
    Deng DX; Li CY; Zheng ZY; Wen B; Liao LD; Zhang XJ; Li EM; Xu LY
    Mol Cell Proteomics; 2023 Aug; 22(8):100593. PubMed ID: 37328063
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study.
    Medas F; Dobrinja C; Al-Suhaimi EA; Altmeier J; Anajar S; Arikan AE; Azaryan I; Bains L; Basili G; Bolukbasi H; Bononi M; Borumandi F; Bozan MB; Brenta G; Brunaud L; Brunner M; Buemi A; Canu GL; Cappellacci F; Cartwright SB; Castells Fusté I; Cavalheiro B; Cavallaro G; Chala A; Chan SYB; Chaplin J; Cheema MS; Chiapponi C; Chiofalo MG; Chrysos E; D'Amore A; de Cillia M; De Crea C; de Manzini N; de Matos LL; De Pasquale L; Del Rio P; Demarchi MS; Dhiwakar M; Donatini G; Dora JM; D'Orazi V; Doulatram Gamgaram VK; Eismontas V; Kabiri EH; El Malki HO; Elzahaby I; Enciu O; Eskander A; Feroci F; Figueroa-Bohorquez D; Filis D; François G; Frías-Fernández P; Gamboa-Dominguez A; Genc V; Giordano D; Gómez-Pedraza A; Graceffa G; Griffin J; Guerreiro SC; Gupta K; Gupta KK; Gurrado A; Hajiioannou J; Hakala T; Harahap WA; Hargitai L; Hartl D; Hellmann A; Hlozek J; Hoang VT; Iacobone M; Innaro N; Ioannidis O; Jang JHI; Xavier-Junior JC; Jovanovic M; Kaderli RM; Kakamad F; Kaliszewski K; Karamanliev M; Katoh H; Košec A; Kovacevic B; Kowalski LP; Králik R; Yadav SK; Kumorová A; Lampridis S; Lasithiotakis K; Leclere JC; Leong EKF; Leow MK; Lim JY; Lino-Silva LS; Liu SYW; Llorach NP; Lombardi CP; López-Gómez J; Lori E; Quintanilla-Dieck L; Lucchini R; Madani A; Manatakis D; Markovic I; Materazzi G; Mazeh H; Mercante G; Meyer-Rochow GY; Mihaljevic O; Miller JA; Minuto M; Monacelli M; Mulita F; Mullineris B; Muñoz-de-Nova JL; Muradás Girardi F; Nader S; Napadon T; Nastos C; Offi C; Ronen O; Oragano L; Orois A; Pan Y; Panagiotidis E; Panchangam RB; Papavramidis T; Parida PK; Paspala A; Pérez ÒV; Petrovic S; Raffaelli M; Ramacciotti CF; Ratia Gimenez T; Rivo Vázquez Á; Roh JL; Rossi L; Sanabria A; Santeerapharp A; Semenov A; Seneviratne S; Serdar A; Sheahan P; Sheppard SC; Slotcavage RL; Smaxwil C; Kim SY; Sorrenti S; Spartalis E; Sriphrapradang C; Testini M; Turk Y; Tzikos G; Vabalayte K; Vargas-Osorio K; Vázquez Rentería RS; Velázquez-Fernández D; Vithana SMP; Yücel L; Yulian ED; Zahradnikova P; Zarogoulidis P; Ziablitskaia E; Zolotoukho A; Calò PG;
    Lancet Diabetes Endocrinol; 2023 Jun; 11(6):402-413. PubMed ID: 37127041
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effectiveness of proton beam therapy for liver oligometastatic recurrence in patients with postoperative esophagus cancer.
    Yamaguchi H; Kato T; Honda M; Hamada K; Seto I; Tominaga T; Takagawa Y; Takayama K; Suzuki M; Kikuchi Y; Teranishi Y; Murakami M
    J Radiat Res; 2023 May; 64(3):582-589. PubMed ID: 36913708
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. etv5 overexpression promotes progression of esophageal squamous cell carcinoma by upregulating SKA1 and TRPV2.
    Sun MC; Fang K; Li ZX; Chu Y; Xu AP; Zhao ZY; Leng ZY; Zhang YW; Zhang ZH; Zhang L; Chen T; Xu MD
    Int J Med Sci; 2022; 19(6):1072-1081. PubMed ID: 35813298
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Rearrangement processes and structural variations show evidence of selection in oesophageal adenocarcinomas.
    Ng AWT; Contino G; Killcoyne S; Devonshire G; Hsu R; Abbas S; Su J; Redmond AM; Weaver JMJ; Eldridge MD; Tavaré S; ; Edwards PAW; Fitzgerald RC
    Commun Biol; 2022 Apr; 5(1):335. PubMed ID: 35396535
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral cancer Treatment.
    Hwang BO; Park SY; Cho ES; Zhang X; Lee SK; Ahn HJ; Chun KS; Chung WY; Song NY
    Front Immunol; 2021; 12():807600. PubMed ID: 34987523
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A New Device for Fine-Needle Aspiration Cytology Consisting of a Vibrating Linear Resonant Actuator.
    Taguchi A; Kojima T; Okanoue Y; Kagoshima H; Hasebe K; Yamamoto H; Hori R
    Laryngoscope; 2021 Apr; 131(4):E1393-E1399. PubMed ID: 33001466
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. etv5 overexpression contributes to tumor growth and progression of thyroid cancer through PIK3CA.
    Meng D; Li Z; Ma X; Wu L; Fu L; Qin G
    Life Sci; 2020 Jul; 253():117693. PubMed ID: 32325133
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ETS Factor etv5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid cancer.
    Bullock M; Lim G; Zhu Y; Åberg H; Kurdyukov S; Clifton-Bligh R
    Thyroid; 2019 Nov; 29(11):1623-1633. PubMed ID: 31452441
    [No Abstract]    [Full Text] [Related]  

  • 12. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct?
    Skálová A; Ptáková N; Santana T; Agaimy A; Ihrler S; Uro-Coste E; Thompson LDR; Bishop JA; Baněčkova M; Rupp NJ; Morbini P; de Sanctis S; Schiavo-Lena M; Vanecek T; Michal M; Leivo I
    Am J Surg Pathol; 2019 Oct; 43(10):1303-1313. PubMed ID: 31162284
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
    Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
    Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma.
    Kacew AJ; Harris EJ; Lorch JH; Haddad RI; Chau NG; Rabinowits G; LeBoeuf NR; Schmults CD; Thakuria M; MacConaill LE; Hanna GJ
    Eur J Cancer; 2019 May; 113():1-9. PubMed ID: 30954880
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Early Recurrence and cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma.
    Hamai Y; Emi M; Ibuki Y; Murakami Y; Nishibuchi I; Nagata Y; Furukawa T; Kurokawa T; Ohsawa M; Okada M
    Anticancer Res; 2019 Mar; 39(3):1433-1440. PubMed ID: 30842179
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
    Sikorska J; Gaweł D; Domek H; Rudzińska M; Czarnocka B
    BMC Cancer; 2019 Jan; 19(1):85. PubMed ID: 30654768
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Isolation and characterization of cells derived from human epithelial rests of Malassez.
    Kitajima K; Das R; Liang X; Neppelberg E; Johannessen AC; Costea DE; Igarashi M
    Odontology; 2019 Jul; 107(3):291-300. PubMed ID: 30478679
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Transcription Factor etv5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid cancer Cells.
    Puli OR; Danysh BP; McBeath E; Sinha DK; Hoang NM; Powell RT; Danysh HE; Cabanillas ME; Cote GJ; Hofmann MC
    Neoplasia; 2018 Nov; 20(11):1121-1134. PubMed ID: 30265861
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer.
    Barros FBA; Assao A; Garcia NG; Nonogaki S; Carvalho AL; Soares FA; Kowalski LP; Oliveira DT
    BMC Cancer; 2018 Jan; 18(1):53. PubMed ID: 29310601
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells.
    Zhang XD; Huang GW; Xie YH; He JZ; Guo JC; Xu XE; Liao LD; Xie YM; Song YM; Li EM; Xu LY
    Nucleic Acids Res; 2018 Feb; 46(4):1793-1809. PubMed ID: 29253179
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.